ArticleBMJ neurology open2026
Reduced intracortical inhibition and enhanced intracortical facilitation in patients with functional tremor.
Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The pathophysiological mechanism underlying functional tremor (FT) has not been elucidated. Transcranial magnetic stimulation (TMS) is a non-invasive tool to explore cortical excitability in various neurological and neuropsychiatric disorders. The aim of this study is to evaluate the changes in cortical excitability in FT and to assess the relationship between cortical excitability and tremor severity. Methods: This study recruited 39 patients with FT and 40 healthy controls (HCs). The clinical characteristics of the patients with FT were assessed using the Simplified Functional Movement Disorders Rating Scale (SFMDRS), Clinical Global Impression Severity Scale, and Symptom Check List-90. Intracortical excitability was assessed, including short/long-interval intracortical inhibition (SICI/LICI) and intracortical facilitation (ICF), in all participants using paired-pulse TMS. Results: Compared with HCs, patients with FT exhibited reduced SICI-2 ms and SICI-4 ms and enhanced ICF-10 ms. Interhemispheric comparisons showed unbalanced excitability with reduced SICI-2 ms, increased ICF-8 ms and increased ICF-10 ms in the more affected side, which were not observed in HCs. The correlation analysis showed that SFMDRS scores were positively correlated with the Hamilton Anxiety Rating Scale and SICI-2 ms. Conclusions: The findings indicate altered cortical excitability in patients with FT. Reduced intracortical inhibition was correlated with tremor severity, suggesting impaired inhibitory pathways in patients with FT. Trial registration number: ChiCTR2200066389; Chinese Clinical Trial Registry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.